Skip to main content

1 Result(s)

within Valentina Screpanti Remove this filter Cancer Research Remove this filter

and

  1. No Access

    Article

    CD4+ T cells kill Id+ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo

    B-lymphoma cells express a highly tumor-specific antigen, monoclonal Ig, which is a promising target for immunotherapy. Previous work has demonstrated that B-lymphoma cells spontaneously process their endogeno...

    Katrin U. Lundin, Valentina Screpanti, Hilde Omholt… in Cancer Immunology, Immunotherapy (2004)